These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 35305566)
1. Longitudinal extensive transverse myelitis after chemoradiation therapy with durvalumab, a rare complication: case report. Moodie T; Alshaqi O; Alchaki A BMC Neurol; 2022 Mar; 22(1):107. PubMed ID: 35305566 [TBL] [Abstract][Full Text] [Related]
2. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M; J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675 [TBL] [Abstract][Full Text] [Related]
3. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B; J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206 [TBL] [Abstract][Full Text] [Related]
4. Long-term response with durvalumab after chemoradiotherapy for pulmonary pleomorphic carcinoma: A case report. Yorozuya T; Taya T; Yasuda K; Nagano Y; Shioya M; Chiba H; Takahashi H Thorac Cancer; 2020 Apr; 11(4):1090-1093. PubMed ID: 32045109 [TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic myelitis associated with durvalumab treatment for extensive-stage small cell lung cancer. Wang L; Lou H; Li B; Li J; Yang YM Invest New Drugs; 2022 Feb; 40(1):151-156. PubMed ID: 34287773 [TBL] [Abstract][Full Text] [Related]
6. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome. Jarius S; Kleiter I; Ruprecht K; Asgari N; Pitarokoili K; Borisow N; Hümmert MW; Trebst C; Pache F; Winkelmann A; Beume LA; Ringelstein M; Stich O; Aktas O; Korporal-Kuhnke M; Schwarz A; Lukas C; Haas J; Fechner K; Buttmann M; Bellmann-Strobl J; Zimmermann H; Brandt AU; Franciotta D; Schanda K; Paul F; Reindl M; Wildemann B; J Neuroinflammation; 2016 Nov; 13(1):281. PubMed ID: 27802825 [TBL] [Abstract][Full Text] [Related]
7. Influenza-associated MOG antibody-positive longitudinally extensive transverse myelitis: a case report. Amano H; Miyamoto N; Shimura H; Sato DK; Fujihara K; Ueno S; Nakamura R; Ueno Y; Watanabe M; Hattori N; Urabe T BMC Neurol; 2014 Nov; 14():224. PubMed ID: 25434485 [TBL] [Abstract][Full Text] [Related]
8. MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentation. Loos J; Pfeuffer S; Pape K; Ruck T; Luessi F; Spreer A; Zipp F; Meuth SG; Bittner S J Neurol; 2020 Jun; 267(6):1632-1642. PubMed ID: 32055995 [TBL] [Abstract][Full Text] [Related]
9. A case report of longitudinal extensive transverse myelitis: immunotherapy related adverse effect Esechie A; Fang X; Banerjee P; Rai P; Thottempudi N Int J Neurosci; 2023 Dec; 133(10):1120-1123. PubMed ID: 35369847 [No Abstract] [Full Text] [Related]
10. A Rare Case of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Transverse Myelitis in a 40-Year-Old Patient With COVID-19. Doukas SG; Santos AP; Mir W; Daud S; Zivin-Tutela TH Cureus; 2022 Apr; 14(4):e23877. PubMed ID: 35530898 [TBL] [Abstract][Full Text] [Related]
11. [Longitudinally extensive transverse myelitis involving fifteen vertebral bodies positive for anti-myelin oligodendrocyte glycoprotein (MOG) antibody: a case report]. Imai T; Shibata S; Shinohara K; Sakurai K; Horiuchi M; Hasegawa Y Rinsho Shinkeigaku; 2019 Jun; 59(6):375-378. PubMed ID: 31142714 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non-small Cell Lung Cancer in the Italian National Health Service. Armeni P; Borsoi L; Fornaro G; Jommi C; Grossi F; Costa F Clin Ther; 2020 May; 42(5):830-847. PubMed ID: 32354495 [TBL] [Abstract][Full Text] [Related]